Jose ramon Ferreres

Dr. Jose ramon Ferreres

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Sebastian PodlipnikSebastian Podlipnik
Sebastian Podlipnik
CCCRISTINA CARRERA
CRISTINA CARRERA
Aram BoadaAram Boada
Aram Boada
NRNina Richarz
Nina Richarz
JMJoaquim Marcoval
Joaquim Marcoval
OCOn Behalf Of The Network Of Melanoma Centres Of Catalonia
On Behalf Of The Network Of Melanoma Centres Of Catalonia
The incidence of melanoma has been increasing worldwide during recent decades. The objective of the study was to analyse the trends in incidence for in situ and invasive melanoma in the Spanish region of Catalonia during the period of 2008–2017. We designed a cross-sectional study with an age-period-cohort analysis of melanoma patient data from the Network of Melanoma Centres in Catalonia. Our database covered a population of over seven million and included a total of 8626 patients with incident melanoma. The main outcome measures were crude and age-standardised incidence rates to the European 2013 standard population. Joinpoint regression models were used to evaluate the population trends. We observed an increase in the age-standardised incidence rate (per 100,000 population) of all melanoma subtypes from 11.56 in 2008 to 13.78 in 2017 with an average annual percent change (AAPC) of 3.5%. This incidence increase was seen exclusively in the older population. Moreover, the stratified analysis showed a statistically significant increase in the age-standardised incidence rate for invasive (AAPC 2.1%) and in situ melanoma (AAPC 6.5%). In conclusion, the incidence of melanoma has continued to increase in the elderly population over recent decades, with a rapidly increasing trend of in situ melanomas and the lentigo maligna subtype.

27 August 2024 in Cancers
Verified
Journal Article
Open access
PDF file
RRRaquel Ramos
Raquel Ramos
AVAntonia Vinyals
Antonia Vinyals
RCRafael Campos-Martin
Rafael Campos-Martin
ECEduard Cabre
Eduard Cabre
JBJoan Josep Bech-Serra
Joan Josep Bech-Serra
ÀFÀngels Fabra
Àngels Fabra
UM is an aggressive intraocular tumor characterized by high plasticity and a propensity to metastasize in the liver. However, the underlying mechanisms governing liver tropism remain poorly understood. Given the emerging significance of exosomes, we sought to investigate the contribution of UM-derived exosomes to specific steps of the metastatic process. Firstly, we isolated exosomes from UM cells sharing a common genetic background and different metastatic properties. A comparison of protein cargo reveals an overrepresentation of proteins related to cytoskeleton remodeling and actin filament-based movement in exosomes derived from the parental cells that may favor the detachment of cells from the primary site. Secondly, we assessed the role of macrophages in reprogramming the HHSCs by exosomes. The activation of HHSCs triggered a pro-inflammatory and pro-fibrotic environment through cytokine production, upregulation of extracellular matrix molecules, and the activation of signaling pathways. Finally, we found that activated HHSCs promote increased adhesion and migration of UM cells. Our findings shed light on the pivotal role of exosomes in pre-metastatic niche construction in the liver.

Verified
Journal Article
Open access
PDF file
AVAntonia Vinyals
Antonia Vinyals
JFJose ramon Ferreres
Jose ramon Ferreres
RCRafael Campos-Martín
Rafael Campos-Martín
OJOlga de la Caridad Jorge-Torres
Olga de la Caridad Jorge-Torres
JMJessica Mainez
Jessica Mainez
ÀFÀngels Fabra Fres
Àngels Fabra Fres
The expression of the Secreted Protein, Acidic and Rich in Cysteine (SPARC) gene in human melanoma increases during progression and is associated with epithelial-to-mesenchymal transition (EMT), which is a major determinant of metastasis in melanoma patients. However, the underlying molecular mechanisms that control SPARC expression in this context remain elusive. Herein, we identified Paired-related homeobox 1 (PRRX1), an EMT transcription factor, as a transcriptional activator of SPARC by direct binding to the promoter, thereby increasing its activity. Moreover, we found a strong positive correlation between SPARC and PRRX1 expression levels in clinical samples and cell lines. Furthermore, the switch from the proliferative/melanocytic phenotype toward the invasive/mesenchymal-like phenotype favors the expression of TCF7L2, a β-catenin cofactor, which, together with Sp1, binds to the proximal SPARC promoter, thereby bolstering protein expression. We also show that SPARC is a target of the miR-29 family, whose members are expressed in clinical melanoma samples and cell lines. Indeed, we found that miR-29b1~a expression is inversely correlated with SPARC levels, and it is significantly reduced in samples with a mesenchymal-like phenotype. Taken together, SPARC expression in melanoma cells relies on transcriptional activation by PRRX1/TCF7L2-Sp1 and is modulated through miR-29b1~a, which provides fine-tuning regulation over the switch between phenotypic states.

1 June 2009
Verified
Journal Article
Closed access
JFJose ramon Ferreres
Jose ramon Ferreres
AMA Moreno
A Moreno
JMJoaquim Marcoval
Joaquim Marcoval

1 January 2017 in Dermatology Online Journal
Verified
Journal Article
Open access
PDF file
JFJose ramon Ferreres
Jose ramon Ferreres
AVAntonia Vinyals-Rioseco
Antonia Vinyals-Rioseco
RPRosa Maria Penin-Mosquera
Rosa Maria Penin-Mosquera
OSOctavio Servitje-Bedate
Octavio Servitje-Bedate
JMJoaquim Marcoval-Caus
Joaquim Marcoval-Caus
AFAngels Fabra-Fres
Angels Fabra-Fres
Medullary carcinoma of the thyroid gland accounts foronly 5-10% of thyroid carcinomas. Also, metastases tothe skin of malignant tumors are infrequently (2-9%of patients). In the case herein reported in a 64-yearoldwoman, a metastatic nodule on the scalp wasthe presenting clinical manifestation of a medullarythyroid carcinoma. A comprehensive review of theliterature was conducted for similar cases usingPubMed. Only 18 cases of cutaneous metastases ofmedullary thyroid carcinoma have been previouslyreported in the literature, but skin lesions were thepresenting complaint of the thyroid neoplasm in onlythree.